60 Degrees Pharmaceuticals Inc. (SXTP)
NASDAQ · Healthcare
60 Degrees Pharmaceuticals Inc. Shareholder Equity 2020–2025
60 Degrees Pharmaceuticals Inc. annual shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- 60 Degrees Pharmaceuticals Inc. shareholder equity as of December 31, 2025: 3.4M, a 14.55% decrease year-over-year.
- 60 Degrees Pharmaceuticals Inc. shareholder equity for 2025 were 3.4M, a 14.55% decrease from 2024.
- 60 Degrees Pharmaceuticals Inc. shareholder equity for 2024 were 4.0M, a 17.57% decrease from 2023.
- 60 Degrees Pharmaceuticals Inc. shareholder equity for 2023 were 4.8M, a 119.87% decrease from 2022.
- 60 Degrees Pharmaceuticals Inc. shareholder equity for 2022 were -24.1M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| 60 Degrees Pharmaceuticals Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $3 |
| 2024 | $4 |
| 2023 | $5 |
| 2022 | $-24 |
| 2021 | $-18 |
| 2020 | $-18 |
60 Degrees Pharmaceuticals Inc. Shareholder Equity — FAQ
60 Degrees Pharmaceuticals Inc. (SXTP) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SXTP's shareholder equity history?
The chart and table above show 60 Degrees Pharmaceuticals Inc.'s shareholder equity by year and by quarter, including the growth rate.